Method of Treating Chronic Myeloid Leukemia Using Pegylated Interferon and Tyrosine Kinase Inhibitor

Described herein is a method of treating chronic myeloid leukemia in a subject including administering to a subject in need thereof a pegylated interferon-a and a BCR-ABL tyrosine kinase inhibitor simultaneously or sequentially.

Saved in:
Bibliographic Details
Main Author Lin, Ko-Chung
Format Patent
LanguageEnglish
Published 06.04.2023
Subjects
Online AccessGet full text

Cover

Loading…